SCHEMBL30485698

SCHEMBL30485698

NS(=O)(=O)c1ccc2cn[nH]c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
KDM4E B2RXH2 1/20 0.55
PKM P14618 1/20 0.55
HTT P42858 1/20 0.55
NOS1 P29475 3/20 0.51
LMNA P02545 2/20 0.51
CYP3A4 P08684 1/20 0.51
ALOX15 P16050 1/20 0.51
DYRK1A Q13627 2/20 0.50
METAP2 P50579 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CASP6 P55212 2/20 0.47
FGFR1 P11362 4/20 0.46
KDR P35968 1/20 0.45
FGFR2 P21802 2/20 0.45
FGFR3 P22607 1/20 0.45
CHEK1 O14757 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23124425 1.00 MAPT (0.55) MAPTMEN1KMT2AKDM4EPKM
SCHEMBL31647068 0.86 KDR (0.57) MAPTMEN1KMT2AKDM4ENOS1
SCHEMBL5220947 0.86 KDR (0.57) MAPTMEN1KMT2AKDM4ENOS1
SCHEMBL6081930 0.83 KDR (0.59) MAPTMEN1KMT2AKDM4EHTT
SCHEMBL8012676 0.82 NOS1 (0.51) MAPTMEN1KMT2AKDM4EPKM
SCHEMBL1076913 0.82 MEN1 (0.55) MAPTMEN1KMT2AKDM4EPKM
SCHEMBL31475220 0.82 NOS1 (0.51) MAPTMEN1KMT2AKDM4EPKM
SCHEMBL4654871 0.82 NOS1 (0.51) MAPTMEN1KMT2AKDM4EPKM
SCHEMBL17824793 0.78 ALDH1A1 (0.50) MAPTMEN1KMT2AKDM4EPKM
SCHEMBL25512612 0.78 MEN1 (0.48) MAPTMEN1KMT2AKDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025229549-A1 NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PARG SATYARX PHARMA INNOVATIONS PVT LTD (IN) 2025-11-06 WO claimed
WO-2025229549-A1 NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PARG SATYARX PHARMA INNOVATIONS PVT LTD (IN) 2025-11-06 WO disclosed
WO-2025072544-A1 SULFONAMINO INDAZOLE COMPOUNDS AS INHIBITORS OF PARG IDEAYA BIOSCIENCES, INC. (US) 2025-04-03 WO disclosed
EP-4479387-A1 INHIBITORS OF PARG ARase Therapeutics Inc. (US) 2024-12-25 EP disclosed
CN-118459452-B PolyADP ribose hydrolase inhibitor and application thereof 苏州国匡医药科技有限公司 2024-10-25 CN disclosed
CN-118459452-A PolyADP ribose hydrolase inhibitor and application thereof 苏州国匡医药科技有限公司 2024-08-09 CN disclosed
WO-2023154913-A1 INHIBITORS OF PARG ARASE THERAPEUTICS INC. (US) 2023-08-17 WO disclosed